loadpatents
Patent applications and USPTO patent grants for Rothe; Mike.The latest application filed is for "human anti-ifn-alpha antibodies".
Patent | Date |
---|---|
Antibodies directed to HER-3 and uses thereof Grant 11,267,900 - Rothe , et al. March 8, 2 | 2022-03-08 |
Human Anti-ifn-alpha Antibodies App 20210221883 - HAQUE; Syeda F. Y. ;   et al. | 2021-07-22 |
CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody Grant 10,975,144 - Hayday , et al. April 13, 2 | 2021-04-13 |
Human anti-IFN-.alpha. antibodies Grant 10,941,198 - Haque , et al. March 9, 2 | 2021-03-09 |
Antibodies Directed To Her-3 And Uses Thereof App 20190263930 - ROTHE; MIKE ;   et al. | 2019-08-29 |
Activated HER3 as a marker for predicting therapeutic efficacy Grant 10,365,283 - Rothe , et al. July 30, 2 | 2019-07-30 |
Human Anti-il-32 Antibodies App 20190112367 - Hayday; Adrian ;   et al. | 2019-04-18 |
Human Anti-ifn-alpha Antibodies App 20190071499 - HAQUE; Syeda F. Y. ;   et al. | 2019-03-07 |
Human anti-IFN-.alpha. antibodies Grant 10,112,995 - Haque , et al. October 30, 2 | 2018-10-30 |
Antibodies directed to HER-3 and uses thereof Grant 10,100,124 - Rothe , et al. October 16, 2 | 2018-10-16 |
Human anti-IL-32 antibodies and methods of making and using the same Grant 10,081,676 - Hayday , et al. September 25, 2 | 2018-09-25 |
Material and methods for treating or preventing HER-3 associated diseases Grant 9,988,462 - Hettmann , et al. June 5, 2 | 2018-06-05 |
Human Anti-ifn-alpha Antibodies App 20170051055 - HAQUE; Syeda F.Y. ;   et al. | 2017-02-23 |
Human Anti-il-32 Antibodies App 20160368981 - HAYDAY; Andrian ;   et al. | 2016-12-22 |
Material And Methods For Treating Or Preventing Her-3 Associated Diseases App 20160222126 - Hettmann; Thore ;   et al. | 2016-08-04 |
Antibodies Directed To Her-3 And Uses Thereof App 20160168264 - ROTHE; MIKE ;   et al. | 2016-06-16 |
Activated Her3 As A Marker For Predicting Therapeutic Efficacy App 20160161491 - ROTHE; Mike ;   et al. | 2016-06-09 |
FGFR4 antibodies Grant 9,284,379 - Bange , et al. March 15, 2 | 2016-03-15 |
Antibodies directed to HER-3 and uses thereof Grant 9,249,230 - Rothe , et al. February 2, 2 | 2016-02-02 |
Axl Antibodies App 20150152193 - HETTMANN; Thore ;   et al. | 2015-06-04 |
AXL antibodies Grant 8,933,202 - Hettmann , et al. January 13, 2 | 2015-01-13 |
Heparin-binding epidermal growth factor-like growth factor binding proteins Grant 8,828,382 - Rothe , et al. September 9, 2 | 2014-09-09 |
Antibodies directed to HER-3 and uses thereof Grant 8,771,695 - Rothe , et al. July 8, 2 | 2014-07-08 |
Fgfr4 Antibodies App 20130183319 - BANGE; Johannes ;   et al. | 2013-07-18 |
FGFR4 antibodies Grant 8,394,927 - Bange , et al. March 12, 2 | 2013-03-12 |
Antibodies Directed to HER-3 and Uses Thereof App 20120058122 - Rothe; Mike ;   et al. | 2012-03-08 |
Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins App 20110110956 - Rothe; Mike ;   et al. | 2011-05-12 |
Antibodies directed to the mammalian EAG1 ion channel protein Grant 7,910,100 - Stuhmer , et al. March 22, 2 | 2011-03-22 |
Axl Antibodies App 20100330095 - Hettmann; Thore ;   et al. | 2010-12-30 |
Antibodies Directed to HER-3 and Uses Thereof App 20100183631 - Rothe; Mike ;   et al. | 2010-07-22 |
Antibodies to tumor necrosis factor receptor associated factor polypeptides Grant 7,754,858 - Goeddel , et al. July 13, 2 | 2010-07-13 |
Fgfr4 Antibodies App 20100169992 - Bange; Johannes ;   et al. | 2010-07-01 |
Antibodies directed to HER-3 and uses thereof Grant 7,705,130 - Rothe , et al. April 27, 2 | 2010-04-27 |
Activated Her3 As A Marker For Predicting Therapeutic Efficacy App 20100047829 - Rothe; Mike ;   et al. | 2010-02-25 |
Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein App 20090028851 - Stuhmer; Walter ;   et al. | 2009-01-29 |
Antibodies directed to HER-3 and uses thereof App 20080124345 - Rothe; Mike ;   et al. | 2008-05-29 |
Tumor Necrosis Factor Receptor-associated Factors App 20070243202 - Goeddel; David V. ;   et al. | 2007-10-18 |
Tumor necrosis factor receptor-associated factors Grant 7,244,836 - Goeddel , et al. July 17, 2 | 2007-07-17 |
IKK-.alpha.proteins, nucleic acids and methods Grant 7,045,613 - Rothe , et al. May 16, 2 | 2006-05-16 |
IKK-alpha proteins, nucleic acids and methods App 20060019365 - Rothe; Mike ;   et al. | 2006-01-26 |
Inhibitors of apoptosis Grant 6,964,765 - Rothe , et al. November 15, 2 | 2005-11-15 |
Inhibitors of apoptosis App 20050037416 - Rothe, Mike ;   et al. | 2005-02-17 |
Inhibitors of apoptosis Grant 6,855,815 - Rothe , et al. February 15, 2 | 2005-02-15 |
Inhibitors of apoptosis Grant 6,821,736 - Rothe , et al. November 23, 2 | 2004-11-23 |
TRAF inhibitors App 20040087774 - Goeddel, David V. ;   et al. | 2004-05-06 |
Inhibitors of apoptosis App 20030143579 - Rothe, Mike ;   et al. | 2003-07-31 |
Tumor necrosis factor receptor-associated factors App 20030120043 - Goeddel, David V. ;   et al. | 2003-06-26 |
IKK-alpha proteins, nucleic acids and methods App 20030077683 - Rothe, Mike ;   et al. | 2003-04-24 |
IKK-.alpha. proteins, nucleic acids and methods Grant 6,235,513 - Rothe , et al. May 22, 2 | 2001-05-22 |
IKK-.alpha. proteins, nucleic acids and methods Grant 6,235,492 - Rothe , et al. May 22, 2 | 2001-05-22 |
c-IAP1 and c-IAP2: inhibitors of apoptosis Grant 6,187,557 - Rothe , et al. February 13, 2 | 2001-02-13 |
Human NIK proteins Grant 5,844,073 - Rothe , et al. December 1, 1 | 1998-12-01 |
Nucleic acids encoding human NIK protein Grant 5,843,721 - Rothe , et al. December 1, 1 | 1998-12-01 |
TRAF inhibitors Grant 5,789,550 - Goeddel , et al. August 4, 1 | 1998-08-04 |
Nucleic acid encoding human signal transducer and activator of transcription 4 Grant 5,756,700 - Hoey , et al. May 26, 1 | 1998-05-26 |
Tumor necrosis factor receptor-associated factors Grant 5,741,667 - Goeddel , et al. April 21, 1 | 1998-04-21 |
Assay for tumor necrosis factor receptor-associated factors Grant 5,670,319 - Goeddel , et al. September 23, 1 | 1997-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.